May 27th, 2021
Incanthera is developing innovative technologies for oncology and dermatology
May 18th, 2021
Incanthera cheers “very important first year”
May 18th, 2021
Incanthera present results of first full year as public company on AQSE
March 23rd, 2021
Incanthera fundraise oversubscribed as it focuses on Sol deal